Cargando…
Diagnostic value of TWEAK for predicting active lupus nephritis in patients with systemic lupus erythematosus: a systematic review and meta-analysis
PURPOSE: Accumulative studies showed that tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) was up-regulated in the blood and urine from patients diagnosed with lupus nephritis (LN) and that it might be used as a novel biomarker for active LN. This meta-analysis aimed to determine t...
Autores principales: | Ma, Hao-Yang, Chen, Shuang, Cao, Wei-Dong, Min, Cui-Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745842/ https://www.ncbi.nlm.nih.gov/pubmed/33307926 http://dx.doi.org/10.1080/0886022X.2020.1853568 |
Ejemplares similares
-
TWEAK: a novel biomarker for lupus nephritis?
por: Dhaun, Neeraj, et al.
Publicado: (2009) -
Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients
por: Liu, Xin-ran, et al.
Publicado: (2023) -
Terbinafine Induced Lupus Erythematosus With Progression to Lupus Nephritis
por: Hindosh, Naif, et al.
Publicado: (2022) -
Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
por: Plüß, Marlene, et al.
Publicado: (2022) -
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study
por: Schwartz, Noa, et al.
Publicado: (2009)